Rao Panduranga S, Schaubel Douglas E, Saran Rajiv
Division of Nephrology, Department of Medicine, School of Public Health, University of Michigan, Ann Arbor, USA.
Nephrol Dial Transplant. 2005 Feb;20(2):387-91. doi: 10.1093/ndt/gfh595. Epub 2004 Dec 7.
While the number of patients returning to dialysis after graft failure (GF) is increasing steadily, the impact of a failed kidney transplant on mortality among dialysis patients has not been studied well.
Data from the Canadian Organ Replacement Register were utilized to examine the outcomes of an incident cohort of patients (n = 25,632) initiating renal replacement therapy (RRT) between 1990 and 1998. Cox regression was used to compare covariate-adjusted mortality among five RRT categories: transplant-naive dialysis, cadaveric primary renal transplant, living-donor primary renal transplant, post-GF dialysis and retransplant. RRT category-specific hazard ratios (HR) were estimated using Cox regression and adjusting for age, sex, race, calendar period, primary renal diagnosis and comorbid conditions.
Mortality among post-GF dialysis patients was approximately equal to that of transplant-naive patients (HR = 0.90; P = 0.30) while the HR for retransplanted patients was significantly decreased, relative to the transplant-naive group (HR = 0.35; P<0.01). Diabetes was found to be a significantly (P<0.01) stronger mortality risk factor among post-GF dialysis patients (HR = 3.71) compared with the transplant-naive group (HR = 1.73). In the post-GF group, cardiovascular disease (HR = 1.66) and 'other serious illness' (HR = 2.07) were found to be much stronger risk factors for mortality than in the transplant-naive group (HR = 1.33 and 1.43, respectively), although the differences failed to reach statistical significance.
These results suggest that transplant-naive and post-GF dialysis patients have equivalent mortality risk and that mortality is significantly reduced upon retransplantation. In addition, the results highlight the importance of diabetes and, possibly, comorbid conditions as potential modifiable risk factors in the management of post-GF dialysis patients.
虽然移植失败(GF)后重返透析的患者数量在稳步增加,但肾移植失败对透析患者死亡率的影响尚未得到充分研究。
利用加拿大器官替代登记处的数据,对1990年至1998年间开始肾脏替代治疗(RRT)的一组患者(n = 25,632)的结局进行研究。采用Cox回归比较五种RRT类别中经协变量调整后的死亡率:未接受过移植的透析患者、尸体供肾初次肾移植患者、活体供肾初次肾移植患者、移植失败后透析患者和再次移植患者。使用Cox回归估计特定RRT类别的风险比(HR),并对年龄、性别、种族、日历时间、原发性肾脏诊断和合并症进行调整。
移植失败后透析患者的死亡率与未接受过移植的患者大致相当(HR = 0.90;P = 0.30),而再次移植患者的HR相对于未接受过移植的组显著降低(HR = 0.35;P<0.01)。与未接受过移植的组(HR = 1.73)相比,糖尿病在移植失败后透析患者中是一个显著更强的死亡风险因素(P<0.01,HR = 3.71)。在移植失败后组中,心血管疾病(HR = 1.66)和“其他严重疾病”(HR = 2.07)被发现是比未接受过移植的组更强的死亡风险因素(分别为HR = 1.33和1.43),尽管差异未达到统计学显著性。
这些结果表明,未接受过移植的透析患者和移植失败后透析患者具有相同的死亡风险,而再次移植后死亡率显著降低。此外,结果强调了糖尿病以及可能的合并症作为移植失败后透析患者管理中潜在可改变风险因素的重要性。